


Searching News Database: Infant Formula
HSMN NewsFeed - 10 Dec 2018
Perrigo Announces the Launch of an AB Rated Generic Version of Topicort(R) Topical Spray 0.25%
Perrigo Announces the Launch of an AB Rated Generic Version of Topicort(R) Topical Spray 0.25%
HSMN NewsFeed - 26 Nov 2018
Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate(R) Lotion 0.05%
Perrigo Announces Tentative FDA Approval For The First To File Generic Version Of Ultravate(R) Lotion 0.05%
HSMN NewsFeed - 1 Oct 2018
Perrigo Confirms Patent Challenge for Generic Version of Jublia(R) Topical Solution 10%
Perrigo Confirms Patent Challenge for Generic Version of Jublia(R) Topical Solution 10%
HSMN NewsFeed - 9 Aug 2018
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex(R)
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex(R)
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace(R) Cream
HSMN NewsFeed - 24 Jan 2018
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo(R) Gel
HSMN NewsFeed - 27 Nov 2017
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
Perrigo Announces the Launch of an AB Rated Generic Version of Exalgo(R) 32mg Extended Release Tablets
HSMN NewsFeed - 2 Nov 2017
Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato(R) Gel 0.05%
Perrigo Announces Tentative FDA Approval for a First-to-File Generic Version of Picato(R) Gel 0.05%
HSMN NewsFeed - 26 Oct 2017
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel
HSMN NewsFeed - 27 Sep 2017
Perrigo Announces First-To-Market Launch of the OTC Store Brand Equivalent Of Nexium(R) 24HR Capsules
Perrigo Announces First-To-Market Launch of the OTC Store Brand Equivalent Of Nexium(R) 24HR Capsules
HSMN NewsFeed - 16 Aug 2017
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog(R) II Cream
Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog(R) II Cream
HSMN NewsFeed - 8 Mar 2017
Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine(R) Foam
Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine(R) Foam
HSMN NewsFeed - 1 Mar 2017
Perrigo Announces FDA Final Approval For The Generic Version Of Axiron(R) Topical Solution, 30 mg/1.5 mL
Perrigo Announces FDA Final Approval For The Generic Version Of Axiron(R) Topical Solution, 30 mg/1.5 mL
HSMN NewsFeed - 17 Feb 2017
Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution
Perrigo Announces FDA Final Approval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution
HSMN NewsFeed - 24 Jan 2017
Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort(R) Spray, 0.25%
Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort(R) Spray, 0.25%
HSMN NewsFeed - 21 Jun 2016
Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market
Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market
HSMN NewsFeed - 2 May 2016
Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel
Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel
HSMN NewsFeed - 10 Nov 2015
Perrigo Announces FDA Approval Of The AB Rated Generic Version Of KlorCon(R) Extended-Release Tablets
Perrigo Announces FDA Approval Of The AB Rated Generic Version Of KlorCon(R) Extended-Release Tablets
HSMN NewsFeed - 28 Aug 2015
Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction
Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction
HSMN NewsFeed - 12 Aug 2013
Teva Pharmaceutical And Perrigo Company Announce The U.S. Launch Of Generic Temozolomide
Teva Pharmaceutical And Perrigo Company Announce The U.S. Launch Of Generic Temozolomide
HSMN NewsFeed - 28 Dec 2012
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
HSMN NewsFeed - 10 Mar 2008
Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
Additional items found! 5
Members Archive contains
5 additional stories matching:
Infant Formula
(Password required)
Infant Formula
(Password required)
